A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Amgen Inc stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 443,907 shares of AMGN stock, worth $141 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares
443,907
Previous 456,300 2.72%
Holding current value
$141 Million
Previous $147 Million 21.31%
% of portfolio
0.26%
Previous 0.35%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

SELL
$258.78 - $328.31 $3.21 Million - $4.07 Million
-12,393 Reduced 2.72%
443,907 $116 Million
Q3 2024

Nov 14, 2024

BUY
$309.38 - $337.38 $1.19 Million - $1.3 Million
3,844 Added 0.85%
456,300 $147 Million
Q2 2024

Aug 14, 2024

BUY
$262.75 - $319.31 $119 Million - $144 Million
452,456 New
452,456 $141 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Mirae Asset Global Etfs Holdings Ltd. Portfolio

Follow Mirae Asset Global Etfs Holdings Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Etfs Holdings Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Etfs Holdings Ltd. with notifications on news.